1. Nutten S. Atopic Dermatitis: Global Epidemiology and Risk Factors. Ann Nutr Metab 2015;66(Suppl 1):8-16.

2. Simpson El et al. Patient Burden of Moderate to Severe Atopic Dermatitis (Ad): Insights from a Phase 2b Clinical Trial of Dupilumab in Adults. Jam Acad Dermatol. 2016;74:491-8.

3. Eichenfield Lf et al. Guidelines of Care for the Management of Atopic Dermatitis. Section 1. Diagnosis and Assessment of Atopic Dermatitis. Jam Acad Dermatol. 2014;70:338-51.

4. Bantz Sk et al. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014.

5. Blauvelt A, de Bruin-Weller M, Gooderham M et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (Liberty AD Chronos): a 1-year, randomized, double-blinded, placebo-controlled, phase 3 trial. Lancet 2017;389(10086):2287-2303.

6. Elias PM, Hatano Y and Williams ML. Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol. 2008; 121(6):1337-1343.

7. European task force on atopic dermatitis. Severity scoring of atopic dermatitis: The scorad index. Dermatology. 1993;186:23-31.

8. Lauffera F. and Ringa J. Target-Oriented Therapy: Emerging drugs for atopic dermatitis. Expert opinion on emerging drugs. 2016; Vol. 21, Nº 1, 81–89.

9. Wahlgren CF. Itch and Atopic Dermatitis. J Dermatol. 1999; 26:770-779.

10. Weidinger S and Novak N. Atopic Dermatitis. Lancet. 2015 Sep 14;387:1109-22.

11. Schneider L, Tilles et al. Atopic Dermatitis: A practice parameter update 2012. J Allergy Clin Immunol. 2013;131:295-299.

12. Boguniewicz M and Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011 Jul;242(1):233-246.

13. Castro APM et al. Guia Prático para o Manejo da Dermatite Atópica - opinião conjunta de especialistas em alergologia da Associação Brasileira de Alergia e Imunopatologia e da Sociedade Brasileira de Pediatria. Rev Bras Alerg Imunolpatol 2006;29(6):268-82.

14. BRANDT EB and SIVAPRASAD U. Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol. 2011; August 10;2(3).

15. Carvalho VO, Solé D et al. Guia prático de atualização em dermatite atópica – Parte II: abordagem terapêutica. Posicionamento conjunto da Associação Brasileira de Alergia e Imunologia e da Sociedade Brasileira de Pediatria. Arq Asma Alerg Imunol. 2017 Feb. Vol.1. Nº 2.

16. Hostetler SG, Kaffenberger B et al. The Role of Airborne Proteins in Atopic Dermatitis. J Clin Aesthet Dermatol. 2010 Jan; 3(1): 22–31.